M, F., CU, N., S, R., EC, R., L, E., A, G., . . . B, E. (2026). Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial. Blood, 147(25), 3025. https://doi.org/10.1182/blood.2025032160
Chicago Style (17th ed.) CitationM, Fürstenau, et al. "Venetoclax Combinations in Untreated CLL: 5-year Results and Patient-reported Outcomes Analysis of the CLL13/GAIA Trial." Blood 147, no. 25 (2026): 3025. https://doi.org/10.1182/blood.2025032160.
MLA (9th ed.) CitationM, Fürstenau, et al. "Venetoclax Combinations in Untreated CLL: 5-year Results and Patient-reported Outcomes Analysis of the CLL13/GAIA Trial." Blood, vol. 147, no. 25, 2026, p. 3025, https://doi.org/10.1182/blood.2025032160.
Warning: These citations may not always be 100% accurate.
